Barriers to Adoption: High Instrument Costs and Reimbursement...

added blog Wellness

2025-12-10 13:00:44 -

Barriers to Adoption: High Instrument Costs and Reimbursement Challenges

Despite the robust growth, the Polymerase Chain Reaction (PCR) Market faces significant restraints that limit its penetration, particularly in resource-constrained settings. High Upfront Capital Cost: Advanced PCR instruments, especially high-throughput quantitative and digital systems, require substantial initial investment. This high cost often deters smaller laboratories, independent...

0 Comments 0 Shares 460 Views 0 Reviews